Kawasaki Disease like Multisystem Inflammatory Syndrome in a Toddler during SARS-CoV-2 Pandemic in Nepal

J Nepal Health Res Counc. 2021 Jan 22;18(4):789-791. doi: 10.33314/jnhrc.v18i4.3281.

Abstract

Multisystem inflammatory syndrome in children is a new childhood inflammatory disorder associated with respiratory syndrome coronavirus 2 (SARS-CoV-2). This illness of elevated inflammatory markers and multiple organ involvement similar to Kawasaki disease is not commonly reported from Asia. A 17-month-old boy presented with acute onset fever, rash, non-exudative conjunctivitis and swellings of hands and legs. In x-ray chest there was infiltration on the right lower lobe and echocardiography showed evidence of coronary arteritis. The diagnosis of multisystem inflammatory syndrome in children was confirmed on the basis of characteristic clinical features and laboratory parameters fulfilling standard case definition for multisystem inflammatory syndrome in children. The child responded to treatment with intravenous immunoglobulin and high dose aspirin. Hence, amidst SARS-CoV-2 pandemic, multisystem inflammatory syndrome in children should be suspected and effectively treated even in a country like Nepal. Keywords: Kawasaki disease; multiple inflammatory syndrome in children; Nepal; respiratory syndrome coronavirus 2.

Publication types

  • Case Reports

MeSH terms

  • Aspirin / therapeutic use
  • COVID-19 / diagnosis*
  • COVID-19 / pathology
  • COVID-19 Drug Treatment
  • Humans
  • Immunoglobulins / therapeutic use
  • Infant
  • Male
  • Nepal
  • Systemic Inflammatory Response Syndrome / diagnosis*
  • Systemic Inflammatory Response Syndrome / drug therapy
  • Systemic Inflammatory Response Syndrome / pathology

Substances

  • Immunoglobulins
  • Aspirin

Supplementary concepts

  • pediatric multisystem inflammatory disease, COVID-19 related